View of A 10-year-long ongoing complete response to vismodegib as first-line treatment in adult metastatic medulloblastoma

Return to Article Details A 10-year-long ongoing complete response to vismodegib as first-line treatment in adult metastatic medulloblastoma Download Download PDF